• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巩膜区域性厚度作为中心性浆液性脉络膜视网膜病变的危险因素。

REGIONAL SCLERAL THICKNESS AS A RISK FACTOR FOR CENTRAL SEROUS CHORIORETINOPATHY.

机构信息

Vitreous, Retina, Macula Consultants of New York, New York, New York.

出版信息

Retina. 2022 Jul 1;42(7):1231-1237. doi: 10.1097/IAE.0000000000003485.

DOI:10.1097/IAE.0000000000003485
PMID:35344531
Abstract

PURPOSE

To evaluate regional sclera thicknesses as possible risk factors for central serous chorioretinopathy (CSC).

METHODS

Patients with CSC and controls were evaluated with contact B-scan ultrasonography using a 20 Mhz concentric phased array ultrasound unit and enhanced depth imaging optical coherence tomography to measure the scleral thickness at the equator and posterior pole. The resultant data were evaluated using univariate analysis and generalized estimating equations.

RESULTS

There were 40 patients with CSC with a mean age of 58 years and 23 controls with a mean age of 60.7 years (P = 0.31). The mean subfoveal scleral thicknesses were 1.3 mm in the CSC group and 0.86 mm in the control group (P < 0.001). The mean equatorial scleral thickness was 0.61 mm in the CSC group and 0.42 mm in the control group (P < 0.001). Using generalized estimating equations, the equatorial scleral thickness (P = 0.001), posterior scleral thickness (P < 0.001), and subfoveal choroidal thickness (P = 0.032) were independent predictors of CSC. Once these variables were entered into the equation, neither sex nor age were significant predictors. Generalized estimating equation analysis showed that equatorial, but not posterior, scleral thickness was a significant predictor of subfoveal choroidal thickness.

CONCLUSION

Scleral thicknesses of the posterior and equatorial portions of the eye were found to be significant predictors of CSC, consistent with what was proposed in the theory of venous overload choroidopathy. Direct measurement by high resolution ultrasonography provides independent information about specific regions of the sclera and also avoids making speculative assumptions derived from anterior segment measurements.

摘要

目的

评估巩膜厚度作为中心性浆液性脉络膜视网膜病变(CSC)的可能危险因素。

方法

使用 20MHz 同心相控阵超声探头的接触式 B 超和增强深度成像光学相干断层扫描(OCT)评估 CSC 患者和对照组的巩膜厚度,测量赤道部和后极部的巩膜厚度。使用单变量分析和广义估计方程评估所得数据。

结果

40 例 CSC 患者平均年龄 58 岁,23 例对照组平均年龄 60.7 岁(P = 0.31)。CSC 组的平均黄斑下巩膜厚度为 1.3mm,对照组为 0.86mm(P < 0.001)。CSC 组的赤道部巩膜厚度平均为 0.61mm,对照组为 0.42mm(P < 0.001)。使用广义估计方程,赤道部巩膜厚度(P = 0.001)、后巩膜厚度(P < 0.001)和黄斑下脉络膜厚度(P = 0.032)是 CSC 的独立预测因素。一旦将这些变量纳入方程,性别和年龄均不是显著的预测因素。广义估计方程分析显示,赤道部而非后巩膜厚度是黄斑下脉络膜厚度的显著预测因素。

结论

眼后极部和赤道部巩膜厚度是 CSC 的显著预测因素,与静脉充血性脉络膜病变理论一致。高分辨率超声直接测量提供了有关巩膜特定区域的独立信息,并且避免了从前段测量得出推测性假设。

相似文献

1
REGIONAL SCLERAL THICKNESS AS A RISK FACTOR FOR CENTRAL SEROUS CHORIORETINOPATHY.巩膜区域性厚度作为中心性浆液性脉络膜视网膜病变的危险因素。
Retina. 2022 Jul 1;42(7):1231-1237. doi: 10.1097/IAE.0000000000003485.
2
Scleral Thickness in Central Serous Chorioretinopathy.脉络膜视网膜病变中心性浆液性。
Ophthalmol Retina. 2021 Mar;5(3):285-291. doi: 10.1016/j.oret.2020.07.011. Epub 2020 Jul 16.
3
SCLERAL THICKNESS IN THE FELLOW EYES OF PATIENTS WITH UNILATERAL CENTRAL SEROUS CHORIORETINOPATHY.单侧中心性浆液性脉络膜视网膜病变患者对侧眼巩膜厚度。
Retina. 2023 Sep 1;43(9):1573-1578. doi: 10.1097/IAE.0000000000003850.
4
Relationship Between Scleral Thickness and Choroidal Structure in Central Serous Chorioretinopathy.巩膜厚度与中心性浆液性脉络膜视网膜病变脉络膜结构的关系。
Invest Ophthalmol Vis Sci. 2023 Jan 3;64(1):16. doi: 10.1167/iovs.64.1.16.
5
Scleral Thickness in Simple Versus Complex Central Serous Chorioretinopathy.单纯型与复合型中心性浆液性脉络膜视网膜病变的巩膜厚度比较。
Am J Ophthalmol. 2024 May;261:103-111. doi: 10.1016/j.ajo.2024.01.025. Epub 2024 Jan 26.
6
A pilot study of scleral thickness in central serous chorioretinopathy using anterior segment optical coherence tomography.前节光学相干断层扫描在中心性浆液性脉络膜视网膜病变巩膜厚度研究中的初步应用。
Sci Rep. 2021 Mar 12;11(1):5872. doi: 10.1038/s41598-021-85229-y.
7
CILIOCHOROIDAL EFFUSION IN CENTRAL SEROUS CHORIORETINOPATHY.脉络膜渗漏在中心性浆液性脉络膜视网膜病变中的表现。
Retina. 2022 Apr 1;42(4):730-737. doi: 10.1097/IAE.0000000000003376.
8
Assessment of the anterior scleral thickness in central serous chorioretinopathy patients by optical coherence tomography.光学相干断层扫描评估中心性浆液性脉络膜视网膜病变患者的前巩膜厚度。
Jpn J Ophthalmol. 2021 Nov;65(6):769-776. doi: 10.1007/s10384-021-00870-4. Epub 2021 Sep 7.
9
Clinical Factors Related to Loculation of Fluid in Central Serous Chorioretinopathy.与中心性浆液性脉络膜视网膜病变液体积聚相关的临床因素。
Am J Ophthalmol. 2022 Mar;235:197-203. doi: 10.1016/j.ajo.2021.09.009. Epub 2021 Sep 20.
10
SUBFOVEAL CHOROIDAL THICKNESS AND VASCULAR DIAMETER IN ACTIVE AND RESOLVED CENTRAL SEROUS CHORIORETINOPATHY.活动性和消退期中心性浆液性脉络膜视网膜病变的黄斑中心凹下脉络膜厚度及血管直径
Retina. 2018 Jan;38(1):102-107. doi: 10.1097/IAE.0000000000001502.

引用本文的文献

1
Evaluation of anterior scleral thickness in eyes with central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变患者眼前巩膜厚度的评估。
Indian J Ophthalmol. 2025 Jun 1;73(6):833-836. doi: 10.4103/IJO.IJO_3116_24. Epub 2025 May 28.
2
Choroidal circulation time by wide-field indocyanine green angiography in central serous chorioretinopathy.广角吲哚菁绿血管造影术测量中心性浆液性脉络膜视网膜病变的脉络膜循环时间
Jpn J Ophthalmol. 2025 Apr 18. doi: 10.1007/s10384-025-01188-1.
3
Multiple serous retinal detachments after Anti-VEGF Intravitreal Injection for pachychoroid related choroidal neovascularization.
抗VEGF玻璃体内注射治疗厚脉络膜相关脉络膜新生血管后出现多发性浆液性视网膜脱离
Am J Ophthalmol Case Rep. 2024 Oct 18;36:102195. doi: 10.1016/j.ajoc.2024.102195. eCollection 2024 Dec.
4
Influence of scleral thickness on photodynamic therapy outcomes in central serous chorioretinopathy.巩膜厚度对中心性浆液性脉络膜视网膜病变光动力疗法疗效的影响。
Acta Ophthalmol. 2025 May;103(3):e165-e175. doi: 10.1111/aos.16779. Epub 2024 Oct 20.
5
Central serous chorioretinopathy and the sclera: what we have learned so far.中心性浆液性脉络膜视网膜病变与巩膜:目前我们的认识。
Jpn J Ophthalmol. 2024 Sep;68(5):419-428. doi: 10.1007/s10384-024-01101-2. Epub 2024 Aug 16.
6
Pachychoroid disease: review and update.厚脉络膜疾病:综述与更新
Eye (Lond). 2025 Apr;39(5):819-834. doi: 10.1038/s41433-024-03253-4. Epub 2024 Aug 3.
7
Biomechanical properties measured with dynamic Scheimpflug analyzer in central serous chorioretinopathy.应用动态 Scheimpflug 分析仪测量中心性浆液性脉络膜视网膜病变的生物力学特性。
Graefes Arch Clin Exp Ophthalmol. 2024 Jun;262(6):1795-1803. doi: 10.1007/s00417-024-06378-0. Epub 2024 Jan 29.
8
Macular neovascularization and polypoidal choroidal vasculopathy: phenotypic variations, pathogenic mechanisms and implications in management.黄斑新生血管和息肉样脉络膜血管病变:表型变异、发病机制及其在治疗中的意义。
Eye (Lond). 2024 Mar;38(4):659-667. doi: 10.1038/s41433-023-02764-w. Epub 2023 Oct 6.
9
Differences in Central and Peripheral Choroidal Thickness among the Subtypes of Age-Related Macular Degeneration in an Asian Population.亚洲人群年龄相关性黄斑变性各亚型中央和周边脉络膜厚度的差异
J Clin Med. 2023 Aug 18;12(16):5364. doi: 10.3390/jcm12165364.
10
Scleral Thickness as a Risk Factor for Central Serous Chorioretinopathy and Pachychoroid Neovasculopathy.巩膜厚度作为中心性浆液性脉络膜视网膜病变和厚脉络膜新生血管病变的危险因素
J Clin Med. 2023 Apr 24;12(9):3102. doi: 10.3390/jcm12093102.